Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. STUB
5. WYFI
6. CRS
7. EAT
8. FRMI
9. ANDG
10. GO

Go back to Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125
(NASDAQ: AXLA) Delayed: 4.58 --0 (-0%)
Previous Close $4.58    52 Week High $ 
Open $4.50    52 Week Low $ 
Day High $4.58    P/E N/A 
Day Low $4.58    EPS $ 
Volume 735,816